Advertisement

Experientia

, Volume 33, Issue 9, pp 1204–1205 | Cite as

A cannabinoid with cardiovascular activity but no overt behavioral effects

  • M. D. Adams
  • J. T. Earnhardt
  • B. R. Martin
  • L. S. Harris
  • W. L. Dewey
  • R. K. Razdan
Pharmacologica

Summary

Abnormal-Δ8-tetrahydrocannabidiol (ABN-Δ8-THC) failed to elicit central nervous system and cardiovascular effects in laboratory animals. Abnormal-cannabidiol (ABN-CBD) was also devoid of overt behavioral effects but produced marked hypotension with only slight bradycardia in anesthesized dogs.

Keywords

Nervous System Central Nervous System Cardiovascular Effect Laboratory Animal Behavioral Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 4.
    R. Mechoulam, N. K. McCallum and S. Burstein, Chem. Rev.76, 75 (1976).Google Scholar
  2. 5.
    R. K. Razdan, H. C. Dalzell and G. R. Handrick, J. Am. Chem. Soc.96, 5860 (1974).PubMedGoogle Scholar
  3. 6.
    T. Petrizilka, W. Haefligen and C. Sikemeier, Helv. Chim. Acta52, 1102 (1969).Google Scholar
  4. 7.
    B. R. Martin, W. L. Dewey, L. S. Harris and J. Beckner, Pharmac. Biochem. Behav.3, 849 (1975).Google Scholar
  5. 8.
    J. C. Cradock, J. P. Davignon, C. L. Sitherst and A. M. Guarino, J. Pharm. Pharmac.25, 345 (1973).Google Scholar
  6. 9.
    D. Holtzman, R. A. Lovell, J. H. Jaffe and D. X. Freedman, Science163, 1464 (1969).PubMedGoogle Scholar
  7. 10.
    M. D. Brannan, J. D. Proctor and A. J. Wasserman, Fedn Proc.34, 744 (1975).Google Scholar
  8. 11.
    R. P. Walton, L. F. Martin and J. H. Keller, J. Pharmac. exp. Ther.62, 239 (1938).Google Scholar
  9. 12.
    H. F. Hardman, E. F. Domino and M. H. Seevers, Clearinghouse for Federal Scientific and technical Information, AD 707-699, p. 1 (1957).Google Scholar
  10. 13.
    H. F. Hardman, E. F. Domino and M. H. Seevers, Pharmac. Rev.23, 295 (1971).Google Scholar
  11. 14.
    W. L. Dewey, L. S. Harris, J. F. Howes, J. S. Kennedy, F. E. Granchelli, H. G. Pars and R. K. Razdan, Nature, Lond.226, 1265 (1970).Google Scholar
  12. 15.
    M. Perez-Reyes, D. Wagner, M. E. Wall and K. H. Davis, in: Pharmacology of Marihuana, p. 829. Ed. M. C. Braude and S. Szara. Raven Press, New York 1976.Google Scholar
  13. 16.
    R. R. Vollmer, I. Cavero, R. J. Ertel, T. A. Solomon and J. P. Buckley, J. Pharm. Pharmac.26, 186 (1974).Google Scholar

Copyright information

© Birkhäuser Verlag 1977

Authors and Affiliations

  • M. D. Adams
    • 1
    • 2
  • J. T. Earnhardt
    • 1
    • 2
  • B. R. Martin
    • 1
    • 2
  • L. S. Harris
    • 1
    • 2
  • W. L. Dewey
    • 1
    • 2
  • R. K. Razdan
    • 2
  1. 1.Department of PharmacologyMedical College of VirginiaRichmondUSA
  2. 2.Sheehan Institute for Research, Inc.CambridgeUSA

Personalised recommendations